These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10595908)

  • 21. Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma.
    Fukudome Y; Yanagihara K; Takeichi M; Ito F; Shibamoto S
    Int J Cancer; 2000 Nov; 88(4):579-83. PubMed ID: 11058874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E-cadherin in gastric carcinomas related to histological prognostic parameters.
    Stănculescu D; Mărgăritescu C; Stepan A; Mitruţ AO
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1107-12. PubMed ID: 22119833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online.
    Becker KF; Reich U; Schott C; Becker I; Berx G; van Roy F; Höfler H
    Hum Mutat; 1999; 13(2):171. PubMed ID: 10094558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
    Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
    Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family.
    Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Berardi A; Garosi L; Suriano G; Vindigni C; De Stefano A; Leoncini L; Seruca R; Pinto E
    Eur J Surg Oncol; 2007 May; 33(4):448-51. PubMed ID: 17126523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors.
    Fuchs M; Hutzler P; Brunner I; Schlegel J; Mages J; Reuning U; Hapke S; Duyster J; Hirohashi S; Genda T; Sakamoto M; Uberall F; Höfler H; Becker KF; Luber B
    Exp Cell Res; 2002 Jun; 276(2):129-41. PubMed ID: 12027444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain.
    Rodriguez-Sanjuan JC; Fontalba A; Mayorga M; Bordin MC; Hyland SJ; Trugeda S; Garcia RA; Gomez-Fleitas M; Fernandez F; Caldas C; Fernandez-Luna JL
    Eur J Surg Oncol; 2006 Dec; 32(10):1110-3. PubMed ID: 16870389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells.
    Suriano G; Oliveira MJ; Huntsman D; Mateus AR; Ferreira P; Casares F; Oliveira C; Carneiro F; Machado JC; Mareel M; Seruca R
    Hum Mol Genet; 2003 Nov; 12(22):3007-16. PubMed ID: 14500541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.
    Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK
    Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.
    Gamboa-Dominguez A; Seidl S; Reyes-Gutierrez E; Hermannstädter C; Quintanilla-Martinez L; Busch R; Höfler H; Fend F; Luber B
    J Clin Pathol; 2007 Jul; 60(7):756-61. PubMed ID: 17483253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3.
    Fuchs M; Hermannstädter C; Specht K; Knyazev P; Ullrich A; Rosivatz E; Busch R; Hutzler P; Höfler H; Luber B
    J Cell Physiol; 2005 Mar; 202(3):805-13. PubMed ID: 15389640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
    Heider KH; Dämmrich J; Skroch-Angel P; Müller-Hermelink HK; Vollmers HP; Herrlich P; Ponta H
    Cancer Res; 1993 Sep; 53(18):4197-203. PubMed ID: 7689929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single amino acid substitutions in conserved extracellular domains of E-cadherin differ in their functional consequences.
    Handschuh G; Luber B; Hutzler P; Höfler H; Becker KF
    J Mol Biol; 2001 Nov; 314(3):445-54. PubMed ID: 11846558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.